Company News, Financial News

Amyris’s Consumer Unit Revenue Rises 92% in 2022

Q4 was a record quarter for biotech ingredients developer and owner of JVN, Biossance, Pipette and Stripes beauty brands.

Author Image

By: Christine Esposito

Editor-in-Chief

Amyris, Inc., the biotechnology company with its own slate of consumer beauty brands, released its financial results for the fourth quarter and full year ended December 31, 2022. “We have focused our brand leadership teams and are making differentiated portfolio choices placing our investment on attractive beauty categories such as skin care, hair care, color cosmetics, baby care and healthy aging with our flagship brands Biossance, JVN, Rose Inc., Pipette, Stripes and MenoLabs,” ...

Continue reading this story and get 24/7 access to Happi for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Happi Newsletters